| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105534 Imidazo[1,2-α]pyridine ether compounds as ion channel modulators |
| 09/12/2006 | US7105533 3-(3-methoxy-4-(pyridin-2-yl)phenyl)imidazo[1,5-a]pyridine hydrochloride; mGluR5 modulators treating psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, pain |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105531 Tricyclic protein kinase inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105525 6-alkoxy-pyrido-pyrimidines |
| 09/12/2006 | US7105524 2-(3,4,4-Trifluoro-but-3-enylsulfanyl)-thiazolo[5,4-b]pyridine; treating, controlling warm-blooded animals, fish and humans against infestation and infection by nematodes, helminths, arachnids and arthropod endo- and ectoparasites. |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105515 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide for treating anxiety, depression, cognitive memory disorders and senile dementia, psychosis, infant hyperkinesia (ADHD, attention deficit/hyperactivity disorder) |
| 09/12/2006 | US7105510 dipyrido [1,4] diazepine derivatives; treating and preventing hiv |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105506 For therapy of cardiovascular disorders and erectile dysfunction |
| 09/12/2006 | US7105505 Benzimidazole derivatives useful as histamine H3 antagonists |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | CA2307037C Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2180730C Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006094235A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | WO2006093801A1 Thiadiazine derivatives useful as anti-infective agents |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006092731A1 1, 2, 4-triazole derivatives and their use as oxytocin antagonists |
| 09/08/2006 | WO2006092722A1 Peptidomimetic compounds and preparation of biologically active derivatives |
| 09/08/2006 | WO2006092599A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 09/08/2006 | WO2006092049A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 09/08/2006 | WO2006092032A2 PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYL-3,6,7,8-TETRAHYDROPIRAZOLO[3,4-b]PIRROLO[4,3-d]PYRIDINE-6,8-DIONE DERIVATIVES, USE, AND PROCESS FOR PREPARING THEM |
| 09/08/2006 | WO2006068821A3 Processes for the preparation of 3,4-substituted-1,2,5-thiadiazoles and intermediates thereof |
| 09/08/2006 | WO2005086700A3 Hiv integrase inhibitors |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599987A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | CA2599876A1 Peptidomimetic compounds and preparation of biologically active derivatives |
| 09/08/2006 | CA2599843A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 09/07/2006 | US20060199962 1-Methoxy-3-(3-methoxy-4-nitrobenzoyl)-2-methylindolizin-6-yl]carboxamide; angiogenesis inhibitors; antitumor, -carcinogenic, and metastasis agent; rheumatic diseases; antiarthritic agents; atherosclerosis; retenosis; leukemia; cardiotonic agents; imflammatory bowel disease; obesity; antidiabetic agents |
| 09/07/2006 | US20060199837 Substituted tetrahydro-1h-pyrazolo [3,4-c]pyridines compositions comprising them, and use |
| 09/07/2006 | US20060199835 Neuroprotective and anti-proliferative compounds |
| 09/07/2006 | US20060199833 Novel chemiluminescent compounds and their use |
| 09/07/2006 | US20060199829 Inhibitors of histone deacetylase |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199823 Corticotropin releasing factor (CRF); affective disorders, anxiety disorders, stress-related disorders, eating disorders and substance abuse; eg 5-(1-Ethyl-propyl)-2-(2-methoxy-4-trifluoromethoxy-phenyl)-3,7-dimethyl-5H-pyrrolo[2,3-b]pyrazine |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199794 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1698334A1 Pharmaceutically active isoindoline derivatives |
| 09/06/2006 | EP1697384A1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 09/06/2006 | EP1697378A2 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 09/06/2006 | EP1697377A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 09/06/2006 | EP1697376A1 Spiro-condensed indoline derivatives as pesticides |
| 09/06/2006 | EP1697362A1 Crf receptor antagonists and methods relating thereto |
| 09/06/2006 | EP1697361A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof |
| 09/06/2006 | EP1697360A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt. |
| 09/06/2006 | EP1697359A1 Muscarinic agonists as therapeutic compounds |
| 09/06/2006 | EP1697358A1 Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| 09/06/2006 | EP1697357A2 Tricyclic benzimidazoles |
| 09/06/2006 | EP1697356A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 09/06/2006 | EP1697344A2 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697337A2 Ornithine derivatives as prostaglandin-e2-agonists or antagonists |
| 09/06/2006 | EP1696930A1 Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 09/06/2006 | EP1696927A2 Mitotic kinesin inhibitors |
| 09/06/2006 | EP1696920A2 Compounds and methods for development of ret modulators |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1696912A2 Pyrazolopyridines and analogs thereof |
| 09/06/2006 | EP1562935B1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/06/2006 | EP1487836B1 Ethane-1,2-diamino-bis (2r)-2-bromo-3-phenylpropanoate|, method for production and use thereof |
| 09/06/2006 | EP1385513B1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents |
| 09/06/2006 | CN1829718A Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 09/06/2006 | CN1829712A Nicotinamide derivatives useful as PDE4 inhibitors |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829704A Benzo [1,2,5] thiadiazole compounds as CCK2 modulators |
| 09/06/2006 | CN1829689A Benzylamine derivative |
| 09/06/2006 | CN1829521A Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 09/06/2006 | CN1829517A Guanidino-substituted quinazolinone compounds as MC4-R agonists |
| 09/06/2006 | CN1827733A Organic electroluminescence device |
| 09/06/2006 | CN1827643A Danofloxacin couple and its preparing method and use |
| 09/06/2006 | CN1273452C 7-(4,4-dimethyl-3-aminomethylpentazane-1-yl) substituted quinoline carboxylic acid derivative and its preparation |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | USRE39266 5-[4-[2-[2,4-dimethyl-6-oxo-1,6-dihydro-1-pyrimidinyl]ethoxy]phenyl methyl]thiazolidine-2,4-dione; intermediate compound for antidiabetic drug |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7101893 Treating hyperproliferative disorders; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide |
| 09/05/2006 | US7101892 2-(4-benzenesulfonyl-4-methyl-pentyl)-5-phenyl-2-aza-bicyclo[2.2.1]heptane; useful for treating sleep disorder, depression, anxiety |
| 09/05/2006 | US7101890 Benzazepine derivatives, drugs containing these and use of the same for producing drugs |
| 09/05/2006 | US7101884 Tyrosine kinase inhibitors |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101428 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone |
| 09/05/2006 | CA2259353C Plaster for the transdermal application of pergolide |
| 09/05/2006 | CA2187484C Process for the preparation of enantiomerically pure imidazolyl compounds |
| 08/31/2006 | WO2006091980A1 Process of purifying tadalafil |
| 08/31/2006 | WO2006091975A1 Process of synthesizing tadalafil |
| 08/31/2006 | WO2006091974A1 Tadalafil having a large particle size and a process for preparation thereof |
| 08/31/2006 | WO2006091674A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/31/2006 | WO2006091671A1 Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors |